Healthcare

Direct-to-Consumer Laboratory Testing Market Size Analysis 2022 To 2030

The global direct-to-consumer laboratory testing market size accounted for US$ 2.23 Bn in 2021 and is projected to reach around USD 32.6 Bn by 2030, growing at a CAGR of 34.72% from 2022 to 2030.

Direct-to-Consumer Laboratory Testing Market Size 2022 To 2030

Report Summary

The global direct-to-consumer laboratory testing market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the direct-to-consumer laboratory testing market across the globe.

A comprehensive estimate on the direct-to-consumer laboratory testing market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of direct-to-consumer laboratory testing during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2313

Direct-to-Consumer Laboratory Testing Market Report Scope

Report Coverage Details
Market Size in 2022 USD 3 Billion
Market Size by 2030 USD 32.6 Billion
Growth Rate from 2022 to 2030 CAGR of 34.72%
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered
  • By Product
  • By Test Type
  • By Sample Type
  • By End User

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized direct-to-consumer laboratory testing market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read:  Flavors and Fragrances Market Size Analysis 2022 To 2030

Direct-to-Consumer Laboratory Testing Market Players

The report includes the profiles of key direct-to-consumer laboratory testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area 

  • 23andMe, Inc
  • Ambry Genetics Corp.
  • Ancestry.com LLC
  • Any Lab Test Now, Inc.
  • Color Genomics, Inc
  • Counsyl, Inc.
  • DanteLabs Inc.
  • Direct Laboratory Services, LLC
  • Eastern Biotech & Life Sciences
  • EasyDNA
  • EverlyWell, Inc.,
  • Full Genomes Corporation, Inc.
  • Gene by Gene, Ltd.
  • Genecodebook Oy
  • Genesis Healthcare Co.
  • Genetrainer
  • GHC Genetics UK
  • HealthCheckUSA
  • Home Access Health Corporation
  • International Biosciences
  • Laboratory Corporation of America Holdings
  • LetsGetChecked, Inc.
  • Mapmygenome India Limited
  • Medichecks.com Ltd.
  • MyHeritage Ltd.
  • MyMedLab, Inc.,
  • Myriad Genetics, Inc.
  • Natera, Inc
  • OME Care
  • Pathway Genomics
  • Pixel by LabCorp,
  • Positive Bioscience
  • Quest Diagnostics Incorporated,
  • Request A Test, Ltd.
  • Shuwen Biotech Co. Ltd.
  • Sonora Quest Laboratories,
  • Thryve Inc
  • Ulta Lab Tests, LLC,
  • Veritas Genetics
  • Vitagene, Inc.
  • Walk-In Lab, LLC.,
  • WellnessFX, Inc.
  • Xcode Life Sciences

Market Segmentation

By Product

  • Medical Genetic Laboratory Testing
  • Routine Clinical Laboratory Testing

By Test Type

  • Genetic Testing
  • COVID-19
  • Cancer
  • Diabetes Testing
  • Disease Risk Assessment Testing
  • Sexually Transmitted Disease Testing
  • Routine Testing
  • Complete Blood Count
  • CNS-related/Neurological Disease
  • Thyroid Stimulating Hormone Testing
  • Other

By Sample Type

  • Blood
  • Urine
  • Saliva
  • Others

By End User

  • Hospitals
  • Diagnostic Centers
  • Blood Banks
  • Home Care
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Direct-To-Consumer Laboratory Testing Market 

5.1. COVID-19 Landscape: Direct-To-Consumer Laboratory Testing Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Direct-To-Consumer Laboratory Testing Market, By Product

8.1. Direct-To-Consumer Laboratory Testing Market, by Product, 2022-2030

8.1.1. Medical Genetic Laboratory Testing

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Routine Clinical Laboratory Testing

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Direct-To-Consumer Laboratory Testing Market, By Test Type

9.1. Direct-To-Consumer Laboratory Testing Market, by Test Type, 2022-2030

9.1.1. Genetic Testing

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. COVID-19

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Cancer

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Diabetes Testing

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Disease Risk Assessment Testing

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Sexually Transmitted Disease Testing

9.1.6.1. Market Revenue and Forecast (2017-2030)

9.1.7. Routine Testing

9.1.7.1. Market Revenue and Forecast (2017-2030)

9.1.8. Complete Blood Count

9.1.8.1. Market Revenue and Forecast (2017-2030)

9.1.9. CNS-related/Neurological Disease

9.1.9.1. Market Revenue and Forecast (2017-2030)

9.1.10. Thyroid Stimulating Hormone Testing

9.1.10.1. Market Revenue and Forecast (2017-2030)

9.1.11. Other

9.1.11.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Direct-To-Consumer Laboratory Testing Market, By Sample Type 

10.1. Direct-To-Consumer Laboratory Testing Market, by Sample Type, 2022-2030

10.1.1. Blood

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Urine

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Saliva

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Direct-To-Consumer Laboratory Testing Market, By End User 

11.1. Direct-To-Consumer Laboratory Testing Market, by End User, 2022-2030

11.1.1. Hospitals

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Diagnostic Centers

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Blood Banks

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Home Care

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Direct-To-Consumer Laboratory Testing Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.1.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.1.4. Market Revenue and Forecast, by End User (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.1.5.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.1.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.1.6.4. Market Revenue and Forecast, by End User (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.2.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.2.4. Market Revenue and Forecast, by End User (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.2.5.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.2.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.2.6.4. Market Revenue and Forecast, by End User (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.2.7.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.2.7.4. Market Revenue and Forecast, by End User (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.2.8.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.2.8.4. Market Revenue and Forecast, by End User (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.3.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.3.4. Market Revenue and Forecast, by End User (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.3.5.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.3.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.3.6.4. Market Revenue and Forecast, by End User (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.3.7.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.3.7.4. Market Revenue and Forecast, by End User (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.3.8.4. Market Revenue and Forecast, by End User (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.4.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.4.4. Market Revenue and Forecast, by End User (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.4.5.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.4.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.4.6.4. Market Revenue and Forecast, by End User (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.4.7.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.4.7.4. Market Revenue and Forecast, by End User (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.4.8.4. Market Revenue and Forecast, by End User (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.5.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.5.5.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.5.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Test Type (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Sample Type (2017-2030)

12.5.6.4. Market Revenue and Forecast, by End User (2017-2030)

Chapter 13. Company Profiles

13.1. 23andMe, Inc

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Ambry Genetics Corp.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Ancestry.com LLC

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Any Lab Test Now, Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Color Genomics, Inc

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Counsyl, Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. DanteLabs Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Direct Laboratory Services, LLC

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Eastern Biotech & Life Sciences

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. EasyDNA

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Show More

Related Articles

Back to top button